References
- Abud HE, Watson N, Heath JK. (2005). Growth of intestinal epithelium in organ culture is dependent on EGF signalling. Exp Cell Res 303:252–62
- Alison MR, Chinery R, Poulsom R, et al. (1995). Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal TFF, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 175:405–14
- Berlanga J, Lodos J, Lopez-Saura P. (2002). Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents. Burns 28:435–42
- Berlanga J, Prats P, Remirez D, et al. (2002). Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage. Am J Pathol 161:373–9
- Clark JA, Clark AT, Hotchkiss RS, et al. (2008). Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis. Shock 30:36–42
- Cook GA, Thim L, Yeomans ND, Giraud AS. (1998). Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats. J Gastroenterol Hepatol 13:363–70
- Dominguez JA, Coopersmith CM. (2010). Can we protect the gut in critical illness? The role of growth factors and other novel approaches. Crit Care Clin 26:549–65
- Fiddian-Green RG. (1992). The role of gut in shock and resuscitation. Clin Intensive Care 3:5–11
- Gatt M, Reddy BS, MacFie J. (2007). Review article: bacterial translocation in the critically ill – evidence and methods of prevention. Aliment Pharmacol Ther 25:741–57
- Goldstein B, Giroir B, Randolph A. (2005). International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8
- Hoffmann W, Jagla W, Sjede A. (2001). Molecular medicine of TFF-peptides: from gut to brain. Histol Histopathol 16:319–34
- Jones MK, Tomikawa M, Mohajer B, Tarnawski AS. (1999). Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci 4:D303–9
- Leteurtre S, Martinot A, Duhamel A, et al. (1999). Development of a pediatric multiple organ dysfunction score: use of two strategies. Med Decis Making 19:399–410
- Pierro A, Eaton S. (2004). Intestinal ischemia reperfusion injury and multisystem organ failure. Semin Pediatr Surg 13:11–17
- Rio MC, Bellocq JP, Daniel JY, et al. (1988). Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 241:705–8
- Rio MC, Chenard MP, Wolf C, et al. (1991). Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100:375–9
- Schwartz N, Hosford M, Sandoval RM, et al. (1999). Ischemia activates actin depolymerizing factor: role in proximal tubule microvillar acetin alterations. Am J Physiol 276:F544–51
- Thim L; A new family of growth factor-like peptides. (1989). ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP) and frog skin peptides (spasmolysins). FEBS Lett 250:85–90
- Thuijls G, Derikx JPM, Grootjans J, et al. (2011). Intestinal barrier loss in sepsis. Neth J Crit Care 15:199–203
- Tran CP, Cook GA, Yeomans ND, et al. (1999). Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 44:636–42
- van Haren FM, Sleigh JW, Pickkers P, Van der Hoeven JG. (2007). Gastrointestinal perfusion in septic shock. Anaesth Intensive Care 35:679–94